A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects
Completed · Phase 4
Conditions studied: Healthy
In brief
An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
Key facts
- Study ID
- NCT00666705
- Run by
- ViiV Healthcare
- People needed
- 18
- Starts
- 2008-02-01
- Expected to finish
- 2008-03-01
- Last updated by the study team
- 2013-01-25
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male and/or female subjects between 18 and 55 years of age.
You may not qualify if…
- Evidence or history of clinically significant disease or clinical findings at screening
Where it is running
- Pfizer Investigational Site — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.